Naproxen
- Product NDC
- 65162-188
- 11-digit product format
- 651620188
- Labeler code
- 65162
- Product ID
- 65162-188_691465d4-c26e-4118-9578-bec8d788f33b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals LLC
- Application
- ANDA075927
- Marketing category
- ANDA
- Marketing start
- 2010-02-18
- Substance
- NAPROXEN
- Active strength
- 250 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Naproxen
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| NAPROXEN | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 57Y76R9ATQ |
| Rxcui | 198012, 198013, 198014 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 65162-188-10 | Naproxen | 100 in 1 BOTTLE | TABLET | 100 | | 30 |
| 65162-188-11 | Naproxen | 1000 in 1 BOTTLE | TABLET | 1000 | | 30 |
| 65162-188-50 | Naproxen | 500 in 1 BOTTLE | TABLET | 500 | | 30 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| NAPROXEN | ACTIVE INGREDIENT | 57Y76R9ATQ | NAPROXEN TABLET [PD-RX PHARMACEUTICALS, INC.] | 10 | |
| NAPROXEN | ACTIVE MOIETY | 57Y76R9ATQ | NAPROXEN TABLET [PD-RX PHARMACEUTICALS, INC.] | 10 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | NAPROXEN TABLET [PD-RX PHARMACEUTICALS, INC.] | 10 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | NAPROXEN TABLET [PD-RX PHARMACEUTICALS, INC.] | 10 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | NAPROXEN TABLET [PD-RX PHARMACEUTICALS, INC.] | 10 | |
| NAPROXEN | ACTIVE INGREDIENT | 57Y76R9ATQ | NAPROXEN TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 9 | |
| NAPROXEN | ACTIVE MOIETY | 57Y76R9ATQ | NAPROXEN TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 9 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | NAPROXEN TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 9 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | NAPROXEN TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 9 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | NAPROXEN TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 9 | |
| NAPROXEN | ACTIVE INGREDIENT | 57Y76R9ATQ | NAPROXEN TABLET [AVPAK] | 1 | |
| NAPROXEN | ACTIVE MOIETY | 57Y76R9ATQ | NAPROXEN TABLET [AVPAK] | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | NAPROXEN TABLET [AVPAK] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | NAPROXEN TABLET [AVPAK] | 1 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | NAPROXEN TABLET [AVPAK] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 65162-188 | NAPROXEN TABLET [AMNEAL PHARMACEUTICALS LLC] | 29 | Current NDC, Legacy NDC, 3 package rows | 20241031_c43a43e2-e867-448d-8f59-3efc7c077cbc.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65162-188-10 | 65162018810 | 100 TABLET in 1 BOTTLE (65162-188-10) | 100 tablet | 2010-02-18 | 0000-00-00 | No | No | Current |
| 65162-188-11 | 65162018811 | 1000 TABLET in 1 BOTTLE (65162-188-11) | 1000 tablet | 2010-02-18 | 0000-00-00 | No | No | Current |
| 65162-188-50 | 65162018850 | 500 TABLET in 1 BOTTLE (65162-188-50) | 500 tablet | 2010-02-18 | 0000-00-00 | No | No | Current |